This paper proposes a method to measure efficiency in highly regulated capital-intensive industries in the presence of state-owned enterprises. We generalize the data envelopment analysis method to include regulation in the model, as well as the quasi-fixed nature of capital and its links with...

Sous la direction de Marcelin Joanis et Luc Godbout Avec la collaboration de Laurence Allaire Jean, Jean-Pierre Aubry, Bryan Campbell, Jean-Claude Cloutier, Serge Coulombe, Jonathan Deslauriers, Pouya Ebrahimi, Kodjovi M. Eklou, Étienne Farvaque, Martial Foucault, Robert Gagné, Roger Galipeau,...

Using life expectancy as a general health indicator, results suggest that increases in drug spending could be more than offset by decreases in other healthcare spending without affecting the health of the population. This suggests that better access to drugs may be an effective strategy to...

Background: Drug expenditures per capita have drastically increased over the last quarter century in Canada, with a share of overall healthcare costs rising from 8.8% in 1980 to 16.8% in 2002. Pressure to curb expenditure on drugs has increased accordingly, but containing drug expenditure might...

This paper examines a generalization of cost-production duality for regulated firms. It derives an equivalency between the production function and conditional factor demands for the case where the firm's optimization problem is subject to a set of additional (regulatory) constraints. This...

Inthis paper we develop a new method, based on generalized inverse,to recover the first derivatives of the production function.This allows us to retrieve returns to scale, technological progressand, in a dynamic setting, a measure of the adjustment cost.The method is general and systematic and...